Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Intravenous infliximab biosimilars for treating inflammatory conditions
Drug guidance

Intravenous infliximab biosimilars for treating inflammatory conditions

Musculoskeletal

Gastrointestinal tract

Skin

13 September 2024

Guidance Recommendations

Subsidy status

Back to top